The effects of increasing concentrations of gefitinib on growth of ACCS, ACCS-AS and NA-SCC cells are shown

Cells were incubated with vehicle, ., non-stimulated, or increasing concentration of gefitinib for 24, 48, and 72 hours. Comparison of cellular growth in response to gefitinib (3.75 μM), EGF (100 ng/ml) and vehicle ., non-stimulated. The represent SD of results of separate wells. * p < 0.05, versus similar dosage in parental ACCS cells at 24 and 48 hrs. ** p < 0.05, versus similar dosage in ACCS cells at 24 and 48 hrs.<p><b>Copyright information:</b></p><p>Taken from "Tyrosine-kinase inhibition results in EGFR clustering at focal adhesions and consequent exocytosis in uPAR down-regulated cells of Head and Neck cancers"</p><p>http://www.molecular-cancer.com/content/7/1/47</p><p>Molecular Cancer 2008;7():47-47.</p><p>Published online 3 Jun 2008</p><p>PMCID:PMC2464604.</p><p>